Page 2 - Program In Carcinoid News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Program In Carcinoid. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Program In Carcinoid Today - Breaking & Trending Today

Cabozantinib Efficacy Prompts CABINET Trial Unblinding in Advanced Pancreatic and Extra-Pancreatic NETs

Published: August 24, 2023

Interim data from the phase 3 CABINET trial demonstrated significant improvement in progression-free survival with cabozantinib vs placebo in patients with advanced pancreatic or extra-pancreatic neuroendocrine tumors following progression on prior systemic therapy.

Source: onclive.com

Related Topics:

United StatesJennifer ChanGastrointestinal Cancer CenterProgram In CarcinoidNeuroendocrine Tumors At Dana Farber Cancer InstituteDrug AdministrationClinical TrialsOncology Independent DataSafety MonitoringMedical AffairsSafety Monitoring BoardNeuroendocrine TumorsDana Farber Cancer InstituteCabinet Trial Cabozantinib Vs PlaceboPatients With Advanced Pancreatic Or Extra Neuroendocrine TumorsWill Berg